National Center for Public Policy Research press release


For Release: May 1, 2017
Contact:
Judy Kent at (703) 759-7476 or cell (703) 477-7476 or jkent@nationalcenter.org and David W. Almasi at (703) 568-4727 or DAlmasi@nationalcenter.org

 

Eli Lilly Finally Admits ObamaCare's Failures: New CEO Says Benefits of the Law Have Been "Marginal at Best"

Free Enterprise Project Urges Lilly to Be Part of ObamaCare's Repeal and Replacement; Pharmaceutical Giant Commits to Working with President Trump and Other DC Leaders on Reform

National Center for Public Policy Research Scores Major Free Speech Victory As "Fake Transparency" Shareholder Proposal Is Soundly Defeated

 

Indianapolis, IN / Washington, D.C. - At today's annual meeting of Eli Lilly investors held in Indianapolis, Indiana, in response to a question from a representative of the National Center for Public Policy Research, Eli Lilly CEO Dave Ricks admitted that ObamaCare has not lived up to its promises as the law fails to reward innovation, and said ObamaCare's benefits to the company have been marginal at best.

The National Center for Public Policy Research's Free Enterprise Project (FEP) - the nation's leading proponent of free-market investor activism — has repeatedly worked to hold the pharmaceutical industry responsible for the pain and suffering caused by ObamaCare. The industry's lobbying arm, PhRMA, dedicated $150 million to an advertising campaign promoting ObamaCare, and the industry worked closely to get the law passed through Congress. Eli Lilly is a member of PhRMA.

Justin Danhof"It is incumbent upon corporations that worked to implement ObamaCare to now be part of its solution," said National Center General Counsel and FEP Director Justin Danhof, Esq., who attended today's meeting and submitted questions to Lilly's executives. "I am encouraged that Lilly plans to work with the Trump Administration to correct some of its past mistakes in supporting ObamaCare."

As submitted to the company, Danhof's question at today's meeting read:

Mr. Ricks, millions of Americans are struggling under the market-distorting mechanisms of the Affordable Care Act. Eli Lilly played a major role in that suffering through its integral role in the implementation, promotion and defense of ObamaCare. As you know, PhRMA dedicated $150 million on advertisements to promote ObamaCare. Now that there is an actual opportunity to repeal and replace ObamaCare with a more market-oriented health care delivery system, it is incumbent upon corporations responsible for ObamaCare's creation to be part of its solution.

As the current political climate offers a unique opportunity for both private industry and health care consumers, I have a few quick questions: What message do you have for the millions of Americans who have seen their health care choices diminish, premiums rise, deductibles go through the roof, or well-being otherwise harmed by ObamaCare? Will you commit to work with the Trump Administration on health care reform? And what specific reforms would you suggest to the new President?

Breaking from traditional shareholder meeting formatting, Eli Lilly had Danhof turn in his question in advance and a truncated version was read by the company's corporate secretary. The full text of Danhof's question, as prepared for delivery, is available here.

"It's just too bad Lilly and other pharmaceutical executives that pushed for ObamaCare hadn't listened to our concerns earlier. Any industry that cedes so much control to a centralized government will see its incentives for innovation diminished," noted Danhof. "Lilly learned this lesson the hard way and the American people have needlessly suffered as a result."

In other news from today's shareholder meeting, the National Center once again helped usher defeat of a left-wing shareholder proposal designed to limit free speech rights. In advance of today's meeting, the National Center issued a press release urging all Eli Lilly investors to vote against a "fake transparency" shareholder proposal submitted by the New York State Comptroller.

In that release, Danhof noted that:

Free speech is under attack from liberals in nearly every corner of America. While liberal efforts to silence speech on college campuses and in the media are well known, there is also a coordinated attack on corporate free speech that is being spearheaded by the likes of the New York Comptroller… Under the guise of transparency and good governance, this liberal network launches dozens of assaults annually on corporations that dare to work with pro-business nonprofits and trade associations. We hope that Eli Lilly's investors will join with us in rejecting this insidious attack on free speech.

At today's meeting Lilly's investors voted down the NY Comptroller's proposal.

Today marked the fourth time FEP has participated in a Lilly shareholder meeting. In 2016, after the company participated in a campaign against a religious freedom protection law in Indiana, FEP promoted its own Lilly shareholder proposal that asked the company to identify criteria for operating in regions with significant and systemic human rights violations.

This also marks the fourth time this year that FEP's Director Danhof has confronted health care executives at their shareholder meetings to ask them about their role in ObamaCare and how they might work with the Trump Administration on health care reform.

Another health care provider in the pharmacy industry, Walgreens Boots Alliance, indicated to the National Center in January that it would be willing to help replace ObamaCare. Walgreens Chairman James Skinner told Danhof the company would be willing to work with the Trump Administration in finding a free-market alternative to ObamaCare. Following that meeting, Danhof joined former Rep. J.D. Hayworth on "Newsmax Prime" to discuss why it is important for corporations to work with the Trump Administration on health care reform.

In April, Danhof confronted Humana CEO Bruce Broussard with a similar question. At that meeting, Humana all but abdicated the company's responsibility to be involved in the health care reform process. And last week, Danhof confronted Johnson & Johnson CEO Alex Gorsky with a similar question. Gorsky tried to downplay Johnson & Johnson's responsibility for ObamaCare, but did vow to work with the Trump Administration on reform.

Launched in 2007, the National Center for Public Policy Research's Free Enterprise Project is the nation's preeminent free-market activist group – focusing on shareholder activism and the confluence of big government and big business. Since 2014, National Center representatives have participated in nearly 100 shareholder meetings to advance free-market ideals in the areas of health care, energy, taxes, subsidies, regulations, religious freedom, food policies, media bias, gun rights, workers' rights and many other important public policy issues. This is the eleventh shareholder meeting FEP has attended in 2017.

FEP activism has yielded a tremendous return on investment:

  • FEP's highly-publicized questioning of support for the Clinton Foundation by Boeing and General Electric helped trigger an FBI investigation of the Clinton Foundation's activities that dominated the 2016 presidential campaign.

  • FEP inquiries prompted Facebook to address political bias against conservatives in social media.

  • Company executives acknowledged media bias at ABC News (Disney), the Washington Post and CNN (Time Warner) in response to FEP's challenges, which helped to bring about more objective reporting and more balanced political representation.

  • FEP's "Employee Conscience Protection Project" strengthened protections for the political beliefs and activities of over five million workers at 13 major U.S. corporations.

So far in 2017, FEP has been featured in media outlets including the New York Times, Washington Post, USA Today, Variety, Newsmax TV, Associated Press, Bloomberg, Breitbart, Denver Post, Drudge Report, Business Insider, Orlando Sentinel, National Public Radio, American Family Radio and SiriusXM. In 2016, FEP was also featured in the Washington Times, the Fox News Channel's "Cavuto," the Financial Times, Crain's Chicago Business, the Hollywood Reporter, the Los Angeles Times, Fortune, Newsmax, the Daily Caller, Lifezette, the Seattle Times, the San Francisco Chronicle and the Chicago Tribune among many others. The Free Enterprise Project was also featured in Wall Street Journal writer Kimberley Strassel's 2016 book The Intimidation Game: How the Left is Silencing Free Speech (Hachette Book Group).

The National Center for Public Policy Research, founded in 1982, is a non-partisan, free-market, independent conservative think-tank. Ninety-four percent of its support comes from individuals, less than four percent from foundations and less than two percent from corporations. It receives over 350,000 individual contributions a year from over 96,000 active recent contributors. Sign up for email updates here. Follow us on Twitter at @NationalCenter for general announcements. To be alerted to upcoming media appearances by National Center staff, follow our media appearances Twitter account at @NCPPRMedia.

-30-



Donation button

Home | Donate | Subscribe | Search | About Us | What's New | Blog | Twitter


National Center Logo

20 F Street NW, Suite 700 Washington, D.C. 20001
(202) 507-6398
Fax (301) 498-1301
E-Mail: info@nationalcenter.org
Web: www.nationalcenter.org